Medicine & TechnologyExperts say some patients have significant responses to immunotherapy that last for years. In some circumstances, so many years that it has been thought that these patients may have been treated for their disease.
Researchers studied the venom from 312 honeybees in Perth, Western Australia, England, and Ireland and tested its effects on the clinical subtypes of breast cancer. They were able to generate an anticancer component from the venom that can kill 100% of cancer cells in just one hour.
A new study has demonstrated that a 30-minute radiotherapy technique employed by administering a spherical intrabeam device in the affected part of the body could potentially be as effective as existing conventional therapy procedures. This is after researchers found no significant differences between the methods.
A new study establishes the link between smoking and reduced use of cancer screening services among women, as well as advanced diseases after a cancer diagnosis.
Pregnant women usually have stretch marks and generally causes no harm. But sometimes they could signal a medical condition that should not be ignored.
Scientists found four-stranded DNA structures, called G-quadruplexes in cancer cells that can serve as the weak spots of the cell that could help scientists develop treatment methods for cancer.
A group of researchers has determined that an injectable dye, which glows under near-infrared light, could illuminate cancerous tissues in the primary tumor and affected lymph nodes. The scientists believe that the dye, called indocyanine green, could ensure that surgeries involving malignant tumors would have "clean margins."
Researchers have found that women who receive early treatment for breast cancer are more likely to develop the disease twice as much and also die from an aggressive form of the illness later on. Click the link above to learn more.
Many women diagnosed with early-stage breast cancer, and whose test results for a positive for an inherited genetic variation are getting cancer treatment that is not following present guidelines. This was according to a study published in early February in JAMA Oncology.